A landmark international clinical trial, led in the UK by UCL researchers, has identified the optimal antibiotics for staph blood infection, a breakthrough that is set to reshape treatment for the life-threatening condition. The SNAP trial, funded in the UK by the National Institute for Health and Care Research (NIHR) found that a little used antibiotic, cefazolin, is as effective as and safer than the current UK standard therapy, flucloxacillin, for treating life-threatening staph blood

Tag-uri: Medicamente